rTMS Therapeutic Program offers non-invasive brain stimulation for treatment-resistant mental disorders like depression and OCD. It enhances medication effects, improves cognitive processing, and supports therapies, reducing reliance on medications.

Goals include reducing symptoms, minimizing medication use, improving quality of life, promoting neuroplasticity, preventing relapse, personalizing treatment, and enhancing psychotherapy outcomes. This evidence-based approach provides tailored, effective care for mental health.

This program is offered as part of a comprehensive care plan, complementing medications, psychotherapy, and other behavioural therapies. It is structured to not only alleviate symptoms but also promote long-term brain health, reduce dependency on medication, and prevent relapse.

rTMS uses a magnetic field to stimulate specific areas of the brain associated with mood regulation and mental well-being. For example:

• In depression, it targets the dorsolateral prefrontal cortex, a region that often shows reduced activity.
• In OCD, stimulation occurs in brain regions responsible for compulsive thoughts and behaviors.

Unlike invasive neuro-modulation techniques, rTMS does not require surgery or anaesthesia, making it a safer and more accessible option for patients.

The rTMS therapeutic program includes the following core components:

1. Personalized Treatment Protocols
   • Each patient undergoes a comprehensive assessment by a multidisciplinary team.
   • The stimulation frequency, intensity, and brain regions targeted are tailored to individual clinical presentations and response to therapy.
2. Collaborative and Integrated Care
   • rTMS is combined with medication management, psychotherapy, mindfulness practices, and behavioral therapy to maximize outcomes.
   • Patients benefit from a team of experts, including psychiatrists, psychologists, and therapists.
3. Maintenance and Relapse Prevention
   • Post-treatment, patients can receive periodic booster sessions to sustain improvements and prevent relapses.
4. Non-Invasive and Outpatient
   • Sessions are conducted in a comfortable outpatient setting, requiring no downtime.

The duration of the rTMS program depends on the condition being treated and the severity of symptoms. Below is a general guideline:

• Treatment-Resistant Depression (TRD):
  • Initial course: 4–6 weeks (5 sessions per week; each session lasting 20–40 minutes).
  • Maintenance sessions: Booster treatments as needed (e.g., once per month).
• Obsessive-Compulsive Disorder (OCD):
  • Initial course: 6–8 weeks (5 sessions per week).
  • Follow-up: Monthly booster sessions based on response and patient preference.
• Other Conditions (e.g., Anxiety, PTSD):
  • Customized schedules depending on response, typically ranging from 4–8 weeks.

The rTMS therapeutic program is designed to achieve the following:

1. Reduction in Symptoms
   • Significant alleviation of depressive symptoms, obsessive thoughts, compulsive behaviors, and anxiety.
2. Reduction in Medication Dependency
   • Minimize the need for psychotropic drugs, reducing side effects and enhancing adherence.
3. Improved Quality of Life
   • Promote emotional well-being, improved relationships, and greater functionality in daily life.
4. Neuroplasticity Enhancement
   • Stimulate neural changes in targeted brain areas, improving mood regulation and cognitive processing.
5. Relapse Prevention
   • Prevent recurrence of symptoms by incorporating maintenance booster sessions as part of the treatment plan.
6. Tailored Treatment for Better Effectiveness
   • Provide personalized protocols to address unique patient needs and optimize therapy outcomes.
7. Support for Other Treatments
   • Enhance the effectiveness of psychotherapy and behavioral therapies by facilitating emotional regulation and cognitive change.